Year: 2023

EDMONTON, Alberta, Dec. 06, 2023 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Company” or “Regenx”) (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN:A2DSW3) announces a private placement for gross proceeds up to $1,500,000 at $0.05 per common share. The closing of the offering is subject to all required regulatory approvals, including the acceptance of the Canadian Securities Exchange. The offering is a non-brokered private placement. The Company will not be paying finder’s fees in the closing of the private placement. The Company intends to use the proceeds from the offering for general corporate purposes including general working capital, operating the Catalytic Converter business, and repayment of debt. The Common Shares to be issued under the offering have not been and will not be registered under the U.S. Securities...

R&D Day Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster Launches, Paving the Way to Industry Leadership in ImmunologyDetails strong pipeline including Sanofi’s record 12 blockbuster opportunities under clinical evaluation: 9 innovative medicines and vaccines with €2 to 5 billion peak sales potential, and 3 ‘pipeline-in-a-product’ assets with a potential of over €5 billion peak sales Strategic transformation through R&D features potential multi-indication assets such as amlitelimab, frexalimab and the oral TNFR1si intended to address unmet patient needs in markets with low penetration of advanced therapies Enhanced R&D focus aims to deliver a 50% increase in Phase 3 trials in 2024 and 2025 as well as 25 mid- to late-stage read-outs over the next 2 years Ambition to become...

WESTON, Fla., Dec. 06, 2023 (GLOBE NEWSWIRE) — ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa” or “the Company”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases with high unmet needs, announced today the pricing of a “reasonable best efforts” public offering of 4,000,000 shares of common stock (or pre-funded warrants in lieu thereof) and accompanying Series A and Series B warrants to purchase up to an aggregate of 8,000,000 shares of common stock at a combined public offering price of $1.25, resulting in gross proceeds of approximately $5.0 million. The Series A Warrants to purchase up to an aggregate of 4,000,000 shares of common stock and Series B Warrants to purchase up to an aggregate of 4,000,000 shares of common stock will have an...

SAN JUAN, Puerto Rico, Dec. 06, 2023 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT), (“Red Cat” or the “Company”), today announced the pricing of its previously announced underwritten public offering of 16,000,000 shares of its common stock at a public offering price of $0.50 per share, for gross proceeds of $8,000,000, before deducting underwriting discounts, commissions and offering expenses. All of the shares of common stock are being offered by the Company. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 2,400,000 shares of common stock at the public offering price less discounts and commissions, to cover over-allotments. The offering is expected to close on December 11, 2023, subject to satisfaction of customary closing conditions. The Company intends to use the...

TAMPA, Fla., Dec. 06, 2023 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE: HCI), a holding company with operations in homeowners insurance, information technology services, real estate, and reinsurance, announced today the pricing of its underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $78 per share, for total gross proceeds of approximately $78 million, before deducting underwriting discounts and commissions and other offering expenses payable by HCI Group. All of the shares in the offering are being sold by HCI Group. In addition, HCI Group has granted the underwriters a 30-day option to purchase up to 150,000 additional shares of its common stock at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on December 11, 2023, subject...

SAN DIEGO, Dec. 06, 2023 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM, BEEMW), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and energy security, announced that Lisa Potok has joined the Beam Global executive team as chief financial officer. Ms. Potok is an innovative and strategically focused financial executive with Fortune 500, small and medium-sized company and international experience. She has consistently contributed to growth in profitability while managing public offerings, acquisitions and other strategic initiatives. Immediately prior to her appointment at Beam Global, Ms. Potok was the CFO, Treasurer and Secretary of Nice North America LLC, previously known as Nortek Security & Control, LLC, one of the largest smart residential, commercial and...

New York, Dec. 06, 2023 (GLOBE NEWSWIRE) — Aimei Health Technology Co., Ltd (NASDAQ: AFJK, the “Company”) announced today that it closed its initial public offering of 6,900,000 units at $10.00 per unit, including the full exercise of the underwriters’ option to purchase up to an additional 900,000 units to cover over-allotments. Each unit consists of one ordinary share and one right. Each right entitles the holder thereof to receive one-fifth (1/5) of one ordinary share upon the consummation of an initial business combination. The units are listed on The NASDAQ Global Market (“NASDAQ”) and began trading under the ticker symbol “AFJKU” on December 4, 2023. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on NASDAQ under the symbols “AFJK,” and “AFJKR,” respectively. Spartan...